12.000
+0,00%
2026-08-07
Fundamental Analysis
78 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +88.3% | +285.5% | 3 / 3 | -11.2% | -8.21 pp | +42.00 pp | +360.3% | 0.29 | 2.07 | 3,2 | −11,2% | 2,6 | +88,3% | 2.07 | 2.80 | −25,9% |
| Pts | 12 | 12 | 12 | 0 | 0 | 12 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 12.000 (close price on 2026-08-07)EPS (TTM): 5.785
Financial charts
1.Revenue & growth
VND bn3,22Q3/26
1.Revenue & growth
VND bn3,22Q3/26
2.Profit & growth
VND bn2,56Q3/26
3.Profit mix (Penman)
VND bn26,9Q3/26
4.Margins & cost structure
%63.7%Q3/26
5.Returns & cash cycle
% · days
6.Earnings quality & cash
VND bn20,2Q3/26
7.Asset structure
VND bn72,9Q3/26
8.Funding & debt health
VND bn · times72,9Q3/26
9.Revenue backlog
VND bn7,23Q3/26
10.Valuation
times · %2,1×Q3/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %569Q3/26
Adjusted EPS growth, latest quarter
88.3%
Average adjusted EPS growth, 3 quarters
88.3%
averaged over 1 quarter(s)
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
Share history could not be reconciled
Source: vnstockData through Q3/26